Opioid Release after High-Intensity Interval Training in Healthy Human Subjects
Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebr...
Saved in:
Published in | Neuropsychopharmacology (New York, N.Y.) Vol. 43; no. 2; pp. 246 - 254 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Nature Publishing Group
01.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [
C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise. |
---|---|
AbstractList | Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [11C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise.Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [11C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise. Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [ C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise. Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [ 11 C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise. Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [11 C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise. |
Author | Tuominen, Lauri Kalliokoski, Kari Hirvonen, Jussi Arponen, Eveliina Tuulari, Jetro J Nummenmaa, Lauri Saanijoki, Tiina |
Author_xml | – sequence: 1 givenname: Tiina surname: Saanijoki fullname: Saanijoki, Tiina – sequence: 2 givenname: Lauri surname: Tuominen fullname: Tuominen, Lauri – sequence: 3 givenname: Jetro J surname: Tuulari fullname: Tuulari, Jetro J – sequence: 4 givenname: Lauri orcidid: 0000-0002-2497-9757 surname: Nummenmaa fullname: Nummenmaa, Lauri – sequence: 5 givenname: Eveliina surname: Arponen fullname: Arponen, Eveliina – sequence: 6 givenname: Kari surname: Kalliokoski fullname: Kalliokoski, Kari – sequence: 7 givenname: Jussi surname: Hirvonen fullname: Hirvonen, Jussi |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28722022$$D View this record in MEDLINE/PubMed |
BookMark | eNptkc1r3DAQxUVJaTZpbz0XQS89xFt9W74UQmizgcBCm0JuQpbHu1q8sivJgf3vqyVJaUNPMzC_ebyZd4ZOwhgAofeULCnh-nOYpiUjtF5SoV-hBa0FqRQX9ydoQXTDK8r5_Sk6S2lHCJW10m_QKdM1Y4SxBVqvJz_6Dn-HAWwCbPsMEa_8ZlvdhAwh-XzAxy4-2AHfReuDDxvsA16BHfL2gFfz3gb8Y2534HJ6i173dkjw7qmeo5_fvt5drarb9fXN1eVt5QRluVJt03MLSjKqOqlcoxxhoEWreEdkD8J2UsiG1D0rXjWrieau7YVtHbEtc_wcfXnUneZ2D52DkKMdzBT93saDGa03_06C35rN-GBkzRqpSBH49CQQx18zpGz2PjkYBhtgnJOhDSO8EYKLgn58ge7GOYZyXqFqKbWSvCnUh78d_bHy_OsCsEfAxTGlCL1xPtvsx6NBPxhKzDFQUwI1x0BNCbQsXbxYetb9L_4bfX-iKQ |
CitedBy_id | crossref_primary_10_1038_s41386_019_0368_x crossref_primary_10_1523_JNEUROSCI_2380_20_2020 crossref_primary_10_24193_cbb_2024_28_03 crossref_primary_10_13181_mji_oa_203569 crossref_primary_10_1002_hbm_24224 crossref_primary_10_1098_rstb_2019_0292 crossref_primary_10_1093_scan_nsz042 crossref_primary_10_1016_j_peptides_2020_170348 crossref_primary_10_3233_BPL_190081 crossref_primary_10_1016_j_neuroimage_2020_116922 crossref_primary_10_7717_peerj_11471 crossref_primary_10_1016_j_copsyc_2018_02_021 crossref_primary_10_1080_00222895_2021_1980366 crossref_primary_10_3389_fonc_2021_745280 crossref_primary_10_1016_j_psychsport_2023_102399 crossref_primary_10_1038_s41437_019_0282_3 crossref_primary_10_1177_19417381221075354 crossref_primary_10_1186_s10194_022_01503_y crossref_primary_10_3390_antiox9050445 crossref_primary_10_1016_j_neubiorev_2020_05_005 crossref_primary_10_1097_j_pain_0000000000002165 crossref_primary_10_1021_acschemneuro_7b00489 crossref_primary_10_1016_j_lfs_2024_122799 crossref_primary_10_1186_s40798_024_00718_4 crossref_primary_10_1089_imr_2022_0028 crossref_primary_10_4103_ijcfm_ijcfm_148_20 crossref_primary_10_1080_09593985_2024_2392183 crossref_primary_10_3389_fpsyg_2020_01296 crossref_primary_10_1038_s41398_024_02796_0 crossref_primary_10_1249_MSS_0000000000002895 crossref_primary_10_3389_fnimg_2024_1332384 crossref_primary_10_1007_s00431_025_06022_x crossref_primary_10_1007_s11914_018_0461_9 crossref_primary_10_1007_s12035_023_03247_5 crossref_primary_10_31189_2165_6193_10_3_117 crossref_primary_10_1080_17437199_2020_1728564 crossref_primary_10_1371_journal_pone_0279468 crossref_primary_10_3390_cancers13020264 crossref_primary_10_3390_molecules24224190 crossref_primary_10_1016_j_jpsychires_2024_01_012 crossref_primary_10_1016_j_psyneuen_2021_105173 crossref_primary_10_33881_2011_7191_mct_15101 crossref_primary_10_3758_s13415_019_00710_6 crossref_primary_10_1038_s41386_020_0725_9 crossref_primary_10_1016_j_physbeh_2018_07_010 crossref_primary_10_1021_acs_jmedchem_2c01965 crossref_primary_10_3758_s13415_021_00960_3 crossref_primary_10_3389_fphys_2022_1093965 crossref_primary_10_1002_ejp_1508 crossref_primary_10_1155_2020_7905387 crossref_primary_10_1016_j_peh_2020_100158 crossref_primary_10_1002_ejp_4783 crossref_primary_10_1007_s10902_022_00528_z crossref_primary_10_3390_molecules27092863 crossref_primary_10_1038_s41583_018_0028_x crossref_primary_10_3389_fnhum_2022_997131 crossref_primary_10_1016_j_encep_2023_03_004 crossref_primary_10_3389_fpubh_2021_554291 crossref_primary_10_1080_02791072_2024_2311143 crossref_primary_10_1097_j_pain_0000000000001969 crossref_primary_10_3389_fpsyt_2023_1120230 crossref_primary_10_1186_s12986_021_00573_0 crossref_primary_10_1038_s41380_018_0107_4 crossref_primary_10_1007_s00520_020_05834_x crossref_primary_10_3390_healthcare12212140 crossref_primary_10_1097_PHM_0000000000001705 crossref_primary_10_1155_2022_1764589 crossref_primary_10_14814_phy2_15831 crossref_primary_10_3389_fpsyg_2017_02176 crossref_primary_10_1155_prm_3432659 crossref_primary_10_56984_8ZG2EF824g crossref_primary_10_1007_s10549_017_4571_3 crossref_primary_10_1249_MSS_0000000000002359 crossref_primary_10_1016_j_cobeha_2021_03_026 |
Cites_doi | 10.1371/journal.pone.0114541 10.1073/pnas.0905307106 10.1136/bjsm.32.2.111 10.1348/135910702169358 10.1126/science.1060952 10.1523/JNEUROSCI.5492-10.2011 10.2165/00007256-199724010-00002 10.1093/cercor/bhn013 10.1093/cercor/bhv086 10.1055/s-0033-1347242 10.3389/fphar.2014.00116 10.1111/bph.13812 10.1249/MSS.0000000000000721 10.1007/s40279-015-0321-z 10.1002/hbm.21416 10.1123/jsep.32.2.253 10.1136/bjsports-2013-092576 10.1038/npp.2015.340 10.1073/pnas.0400266101 10.1016/j.brainresbull.2010.07.009 10.1055/s-0031-1287848 10.1136/bjsm.2004.011718 10.1017/S1461145714000704 10.2165/00007256-199213010-00003 10.1016/0005-7916(94)90063-9 10.1016/j.psychsport.2016.09.005 10.1152/japplphysiol.00521.2002 10.1073/pnas.1514996112 10.1111/jnc.12976 10.1006/nimg.1997.0303 10.1038/nrn2333 10.1002/syn.20404 10.1016/0014-2999(89)90582-7 10.3389/fpsyg.2015.01105 10.1016/S0969-8051(02)00411-0 10.1016/j.mhpa.2009.01.002 10.1016/0022-3999(95)00554-4 10.1037/0022-3514.54.6.1063 10.1073/pnas.102174799 10.1007/s40279-015-0365-0 10.1038/npp.2009.129 10.1249/mss.0b013e31806ad73c 10.1093/brain/awm255 10.1038/jcbfm.1989.59 10.1007/s00259-008-0935-6 10.1016/j.biopsych.2012.01.027 10.1016/j.neuropharm.2015.05.022 10.1080/02640414.2010.545427 10.1523/JNEUROSCI.22-12-05100.2002 |
ContentType | Journal Article |
Copyright | Copyright Nature Publishing Group Jan 2018 Copyright © 2018 American College of Neuropsychopharmacology 2018 American College of Neuropsychopharmacology |
Copyright_xml | – notice: Copyright Nature Publishing Group Jan 2018 – notice: Copyright © 2018 American College of Neuropsychopharmacology 2018 American College of Neuropsychopharmacology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1038/npp.2017.148 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest One Psychology |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Physical exercise and μ-opioid system |
EISSN | 1740-634X |
EndPage | 254 |
ExternalDocumentID | PMC5729560 28722022 10_1038_npp_2017_148 |
Genre | Journal Article |
GroupedDBID | --- -DZ -Q- 0R~ 29N 2WC 36B 39C 4.4 406 5RE 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAYXX AAYZH ABAKF ABBRH ABDBE ABFSG ABIVO ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMFV ACMJI ACPRK ACRQY ACSTC ACZOJ ADBBV ADFRT AEFQL AEJRE AEMSY AENEX AESKC AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS ASPBG ATHPR AVWKF AYFIA AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CITATION CS3 DIK DNIVK DPUIP DWQXO E3Z EBLON EBS EE. EIOEI EJD F5P FDB FDQFY FERAY FIGPU FIZPM FSGXE FYUFA GNUQQ GX1 HCIFZ HMCUK HYE HZ~ IWAJR JSO JZLTJ KQ8 M1P M2M M7P NQJWS O9- OK1 P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO PSYQQ Q2X RNT RNTTT ROL RPM SNX SNYQT SOHCF SOJ SRMVM SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D ZGI --K 1B1 53G 5VS AAEDT AALRI AAQFI AAQXK AAXUO ABMAC ABRTQ ABWVN ACIUM ACRPL ACVFH ADCNI ADMUD ADNMO AEUPX AFPUW AGQPQ CAG CGR COF CUY CVF ECM EIF EMB EMOBN FEDTE FGOYB HVGLF IHE LGEZI LOTEE M41 MK0 NADUK NPM NQ- NXXTH PJZUB PPXIY PQGLB R2- RIG RNS RPZ SEW SSZ SV3 ZKB 3V. 7TK 7XB 8FE 8FH 8FK K9. LK8 PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c412t-6b9f3ae65216d56c96c02e84b63d05fe4ad545907f2287827083cbf4abc0ab2c3 |
IEDL.DBID | 7X7 |
ISSN | 0893-133X 1740-634X |
IngestDate | Thu Aug 21 18:30:23 EDT 2025 Mon Jul 21 10:09:36 EDT 2025 Fri Jul 25 09:01:09 EDT 2025 Mon Jul 21 06:06:07 EDT 2025 Thu Apr 24 23:03:35 EDT 2025 Tue Jul 01 01:05:34 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c412t-6b9f3ae65216d56c96c02e84b63d05fe4ad545907f2287827083cbf4abc0ab2c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-2497-9757 |
OpenAccessLink | https://www.nature.com/articles/npp2017148.pdf |
PMID | 28722022 |
PQID | 1975586539 |
PQPubID | 33935 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5729560 proquest_miscellaneous_1920394434 proquest_journals_1975586539 pubmed_primary_28722022 crossref_citationtrail_10_1038_npp_2017_148 crossref_primary_10_1038_npp_2017_148 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-01-01 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York |
PublicationTitle | Neuropsychopharmacology (New York, N.Y.) |
PublicationTitleAlternate | Neuropsychopharmacology |
PublicationYear | 2018 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
References | Z Milanović (BFnpp2017148_CR34) 2015; 45 AH Goldfarb (BFnpp2017148_CR19) 1997; 24 J Hirvonen (BFnpp2017148_CR25) 2009; 36 L Schwarz (BFnpp2017148_CR42) 1992; 13 MAI Aberg (BFnpp2017148_CR2) 2009; 106 S Heijnen (BFnpp2017148_CR23) 2015; 6 CJ Endres (BFnpp2017148_CR16) 2003; 30 WP Morgan (BFnpp2017148_CR35) 1985; 17 Lauri Nummenmaa (BFnpp2017148_CR36) 2017; 175 P Wahl (BFnpp2017148_CR48) 2013; 45 EG Duerden (BFnpp2017148_CR14) 2013; 34 SN Haber (BFnpp2017148_CR21) 2010; 35 P Ekkekakis (BFnpp2017148_CR15) 2011; 41 MSR de Oliveira (BFnpp2017148_CR10) 2010; 83 JJ Frost (BFnpp2017148_CR17) 1989; 9 EE Hall (BFnpp2017148_CR22) 2002; 7 D Watson (BFnpp2017148_CR49) 1988; 54 I Mick (BFnpp2017148_CR33) 2014; 17 D Scully (BFnpp2017148_CR44) 1998; 32 M Titeler (BFnpp2017148_CR46) 1989; 167 BRR Oliveira (BFnpp2017148_CR37) 2015; 6 V Trezza (BFnpp2017148_CR47) 2011; 31 ES Decker (BFnpp2017148_CR11) 2017; 28 M Kilpatrick (BFnpp2017148_CR28) 2007; 39 EH Chartoff (BFnpp2017148_CR7) 2014; 5 GN Ruegsegger (BFnpp2017148_CR39) 2015; 97 AL Sgherza (BFnpp2017148_CR45) 2002; 93 J Fuss (BFnpp2017148_CR18) 2015; 112 G Henriksen (BFnpp2017148_CR24) 2008; 131 S Aaltonen (BFnpp2017148_CR1) 2012; 33 I Liberzon (BFnpp2017148_CR30) 2002; 99 A Colasanti (BFnpp2017148_CR8) 2012; 72 SJ Colcombe (BFnpp2017148_CR9) 2004; 101 H Boecker (BFnpp2017148_CR5) 2008; 18 RN Gunn (BFnpp2017148_CR20) 1997; 6 JK Zubieta (BFnpp2017148_CR53) 2001; 293 A Dietrich (BFnpp2017148_CR12) 2004; 38 KS Weston (BFnpp2017148_CR50) 2014; 48 JS Ramos (BFnpp2017148_CR38) 2015; 45 M Kanning (BFnpp2017148_CR27) 2010; 32 S Leknes (BFnpp2017148_CR29) 2008; 9 MM Bradley (BFnpp2017148_CR6) 1994; 25 ME Jung (BFnpp2017148_CR26) 2014; 9 RM Arida (BFnpp2017148_CR3) 2015; 132 JD Bartlett (BFnpp2017148_CR4) 2011; 29 DJ Scott (BFnpp2017148_CR43) 2007; 61 J-K Zubieta (BFnpp2017148_CR52) 2002; 22 RR Yeung (BFnpp2017148_CR51) 1996; 40 T Saanijoki (BFnpp2017148_CR40) 2015; 47 RK Dishman (BFnpp2017148_CR13) 2009; 2 C Mazzeschi (BFnpp2017148_CR31) 2014; 2014 H Saarimäki (BFnpp2017148_CR41) 2016; 26 I Mick (BFnpp2017148_CR32) 2016; 41 |
References_xml | – volume: 9 start-page: e114541 year: 2014 ident: BFnpp2017148_CR26 publication-title: PLoS ONE doi: 10.1371/journal.pone.0114541 – volume: 106 start-page: 20906 year: 2009 ident: BFnpp2017148_CR2 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0905307106 – volume: 32 start-page: 111 year: 1998 ident: BFnpp2017148_CR44 publication-title: Br J Sports Med doi: 10.1136/bjsm.32.2.111 – volume: 7 start-page: 47 year: 2002 ident: BFnpp2017148_CR22 publication-title: Br J Health Psychol doi: 10.1348/135910702169358 – volume: 293 start-page: 311 year: 2001 ident: BFnpp2017148_CR53 publication-title: Science doi: 10.1126/science.1060952 – volume: 31 start-page: 6362 year: 2011 ident: BFnpp2017148_CR47 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5492-10.2011 – volume: 41 start-page: 641 year: 2011 ident: BFnpp2017148_CR15 publication-title: port Med – volume: 24 start-page: 8 year: 1997 ident: BFnpp2017148_CR19 publication-title: Sports Med doi: 10.2165/00007256-199724010-00002 – volume: 18 start-page: 2523 year: 2008 ident: BFnpp2017148_CR5 publication-title: Cereb Cortex doi: 10.1093/cercor/bhn013 – volume: 26 start-page: 2563 year: 2016 ident: BFnpp2017148_CR41 publication-title: Cereb Cortex doi: 10.1093/cercor/bhv086 – volume: 45 start-page: 827 year: 2013 ident: BFnpp2017148_CR48 publication-title: Horm Metab Res doi: 10.1055/s-0033-1347242 – volume: 5 start-page: 116 year: 2014 ident: BFnpp2017148_CR7 publication-title: Front Pharmacol doi: 10.3389/fphar.2014.00116 – volume: 175 start-page: 2737 issue: 14 year: 2017 ident: BFnpp2017148_CR36 publication-title: British Journal of Pharmacology doi: 10.1111/bph.13812 – volume: 47 start-page: 2604 year: 2015 ident: BFnpp2017148_CR40 publication-title: Med Sci Sports Exerc doi: 10.1249/MSS.0000000000000721 – volume: 45 start-page: 679 year: 2015 ident: BFnpp2017148_CR38 publication-title: Sports Med doi: 10.1007/s40279-015-0321-z – volume: 34 start-page: 109 year: 2013 ident: BFnpp2017148_CR14 publication-title: Hum Brain Mapp doi: 10.1002/hbm.21416 – volume: 32 start-page: 253 year: 2010 ident: BFnpp2017148_CR27 publication-title: J Sport Exerc Psychol doi: 10.1123/jsep.32.2.253 – volume: 48 start-page: 1227 year: 2014 ident: BFnpp2017148_CR50 publication-title: Br J Sports Med doi: 10.1136/bjsports-2013-092576 – volume: 41 start-page: 1742 year: 2016 ident: BFnpp2017148_CR32 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2015.340 – volume: 101 start-page: 3316 year: 2004 ident: BFnpp2017148_CR9 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0400266101 – volume: 83 start-page: 278 year: 2010 ident: BFnpp2017148_CR10 publication-title: Brain Res Bull doi: 10.1016/j.brainresbull.2010.07.009 – volume: 33 start-page: 157 year: 2012 ident: BFnpp2017148_CR1 publication-title: Int J Sports Med doi: 10.1055/s-0031-1287848 – volume: 38 start-page: 536 year: 2004 ident: BFnpp2017148_CR12 publication-title: Br J Sports Med doi: 10.1136/bjsm.2004.011718 – volume: 17 start-page: 2069 year: 2014 ident: BFnpp2017148_CR33 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145714000704 – volume: 13 start-page: 25 year: 1992 ident: BFnpp2017148_CR42 publication-title: Sport Med doi: 10.2165/00007256-199213010-00003 – volume: 25 start-page: 49 year: 1994 ident: BFnpp2017148_CR6 publication-title: J Behav Ther Exp Psychiatry doi: 10.1016/0005-7916(94)90063-9 – volume: 28 start-page: 1 year: 2017 ident: BFnpp2017148_CR11 publication-title: Psychol Sport Exerc doi: 10.1016/j.psychsport.2016.09.005 – volume: 93 start-page: 2023 year: 2002 ident: BFnpp2017148_CR45 publication-title: J Appl Physiol doi: 10.1152/japplphysiol.00521.2002 – volume: 112 start-page: 13105 year: 2015 ident: BFnpp2017148_CR18 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1514996112 – volume: 132 start-page: 206 year: 2015 ident: BFnpp2017148_CR3 publication-title: J Neurochem doi: 10.1111/jnc.12976 – volume: 6 start-page: 279 year: 1997 ident: BFnpp2017148_CR20 publication-title: Neuroimage doi: 10.1006/nimg.1997.0303 – volume: 2014 start-page: 854129 year: 2014 ident: BFnpp2017148_CR31 publication-title: Biomed Res Int – volume: 9 start-page: 314 year: 2008 ident: BFnpp2017148_CR29 publication-title: Nat Rev Neurosci doi: 10.1038/nrn2333 – volume: 61 start-page: 707 year: 2007 ident: BFnpp2017148_CR43 publication-title: Synapse doi: 10.1002/syn.20404 – volume: 167 start-page: 221 year: 1989 ident: BFnpp2017148_CR46 publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(89)90582-7 – volume: 6 start-page: 1890 year: 2015 ident: BFnpp2017148_CR23 publication-title: Front Psychol – volume: 6 start-page: 1105 year: 2015 ident: BFnpp2017148_CR37 publication-title: Front Psychol doi: 10.3389/fpsyg.2015.01105 – volume: 30 start-page: 177 year: 2003 ident: BFnpp2017148_CR16 publication-title: Nucl Med Biol doi: 10.1016/S0969-8051(02)00411-0 – volume: 2 start-page: 4 year: 2009 ident: BFnpp2017148_CR13 publication-title: Ment Health Phys Act doi: 10.1016/j.mhpa.2009.01.002 – volume: 40 start-page: 123 year: 1996 ident: BFnpp2017148_CR51 publication-title: J Psychosom Res doi: 10.1016/0022-3999(95)00554-4 – volume: 54 start-page: 1063 year: 1988 ident: BFnpp2017148_CR49 publication-title: J Pers Soc Psychol doi: 10.1037/0022-3514.54.6.1063 – volume: 99 start-page: 7084 year: 2002 ident: BFnpp2017148_CR30 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.102174799 – volume: 45 start-page: 1469 year: 2015 ident: BFnpp2017148_CR34 publication-title: Sports Med doi: 10.1007/s40279-015-0365-0 – volume: 35 start-page: 4 year: 2010 ident: BFnpp2017148_CR21 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2009.129 – volume: 39 start-page: 1417 year: 2007 ident: BFnpp2017148_CR28 publication-title: Med Sci Sports Exerc doi: 10.1249/mss.0b013e31806ad73c – volume: 131 start-page: 1171 year: 2008 ident: BFnpp2017148_CR24 publication-title: Brain doi: 10.1093/brain/awm255 – volume: 9 start-page: 398 year: 1989 ident: BFnpp2017148_CR17 publication-title: J Cereb Blood Flow Metab doi: 10.1038/jcbfm.1989.59 – volume: 36 start-page: 275 year: 2009 ident: BFnpp2017148_CR25 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-008-0935-6 – volume: 72 start-page: 371 year: 2012 ident: BFnpp2017148_CR8 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2012.01.027 – volume: 17 start-page: 94 year: 1985 ident: BFnpp2017148_CR35 publication-title: Med Sci Sports Exerc – volume: 97 start-page: 171 year: 2015 ident: BFnpp2017148_CR39 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2015.05.022 – volume: 29 start-page: 547 year: 2011 ident: BFnpp2017148_CR4 publication-title: J Sports Sci doi: 10.1080/02640414.2010.545427 – volume: 22 start-page: 5100 year: 2002 ident: BFnpp2017148_CR52 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.22-12-05100.2002 |
SSID | ssj0015768 |
Score | 2.529427 |
Snippet | Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 246 |
SubjectTerms | Affect - physiology Analgesics, Opioid - metabolism Cerebral Cortex - diagnostic imaging Cerebral Cortex - metabolism Cortex (cingulate) Emotions Exercise Exercise - physiology Fentanyl - analogs & derivatives Fentanyl - metabolism Gyrus Cinguli - diagnostic imaging Gyrus Cinguli - metabolism Healthy Volunteers High-Intensity Interval Training Hippocampus - diagnostic imaging Hippocampus - metabolism Human subjects Humans Interval training Male Mood Narcotics Opioid receptors Original Pain Physical training Positron emission tomography Positron-Emission Tomography - methods Prefrontal Cortex - diagnostic imaging Prefrontal Cortex - metabolism Receptors, Opioid, mu - metabolism Reinforcement Thalamus Thalamus - diagnostic imaging Thalamus - metabolism Young Adult |
Title | Opioid Release after High-Intensity Interval Training in Healthy Human Subjects |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28722022 https://www.proquest.com/docview/1975586539 https://www.proquest.com/docview/1920394434 https://pubmed.ncbi.nlm.nih.gov/PMC5729560 |
Volume | 43 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BJiFeEHR8dIzJSLAXFi2xHTt5Qi1aNSGtm6ZO6lsU24moBGlZu4f899w5bkZB8JSHXD7P9v3uw78D-GBsomqt0U3VwkVSGYdTiusoNrVyzjrEDLQb-XKqLm7l13k6DwG3dSir3K6JfqF2S0sx8rMk12maEZHq59XPiLpGUXY1tNB4DPtEXUYlXXreO1wJYWmPInMRoS82D4XvscjOmhWRVSYaV4ps1yT9hTP_LJf8zf5MnsOzABzZqNP0C3hUNQM4GDXoNP9o2QnzpZw-Rj6AJ5chYz6Ak-uOm7o9ZbOHrVbrU39Fz1rdHsDV1WqxXDh2g3YILRvzzcMZlYFEocx90zIfP8SxyWahswRbNKzbydQynw9guBJRaGf9Em4n57MvF1HothBZmfBNpExei7JSaM-VS5XNlY15lUmjhIvTupKlQ7SFvnTN0cvKuEbwZk0tS2Pj0nArXsFes2yqN8CstaKyTlsXlzJXdc4N3saKxBopuMuG8Gn7wwsbqMipI8b3wqfERVagegpSD3omKP2xl151FBz_kDva6q4IE3FdPAybIbzvT-MUorxI2VTLe5LhMe0PFnIIrztV9w_CT-Uccc4Q9M4g6AWInnv3TLP45mm6U_RbEE8e_v-13sJT_ICsi-ocwd7m7r56hzhnY479YD6G_dFkPJ7icXw-vb75BVscAaw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeJuj46BhgJLYXFi2xHSd5mNCATR1bu2nqpL5lsZ2ISltaaCeUf4q_cWfHySgI3vacS5r07ny_-wZ4L1UgiihCNzVi2uNCalQpGnm-LITWSiNmMN3Ig6HoX_Cv43C8Ar-aXhhTVtmcifag1lNlYuS7QRKFYWwGqX6cfffM1iiTXW1WaNRicZxXP9Flm-8dfUH-blF6eDD63PfcVgFP8YAuPCGTgmW5QLsldChUIpRP85hLwbQfFjnPNKIK9BkLit5ETCMEKUoWPJPKzyRVDJ_7AFY5Q1emA6ufDoZn523ewqB3i1sT5qH3N3al9j6Ld8uZGY8ZRHg2xctG8C9k-2eB5m8W7_AJrDmoSvZr2XoKK3nZhfX9Et3064psE1s8aqPyXXg4cDn6Lmyf1dOwqx0yumvumu_YO9o52dU6nJ7OJtOJJudo-dCWEruunJjCE88V1i8qYiOWqA1k5HZZkElJ6t6pitgMBMGzzwST5s_g4l448Rw65bTMXwJRSrFc6UhpP-OJKBIq8TGKBUpyRnXcgw_NH54qN_zc7OC4Sm0SnsUpsic17EFfCKm3WupZPfTjH3SbDe9Sp_rz9E5Qe_CuvYxKazIxWZlPbwwN9U1HMuM9eFGzuv0h_FRKEVn1IFoSgpbADARfvlJOvtnB4CF6SohgN_7_Wm_hUX80OElPjobHr-Axfkxcx5Q2obP4cZO_RpS1kG-caBO4vG9tugUM5TyN |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4aQ5p4QdBx6RhgJLYXFjWxHTt5QGhiVBtjF6FO6lsW24moxNJu7TTlr-3Xcew4GQXB255zkiY9t-_43ADeKx2JUkoMUyUzARfKoEpRGYSqFMZog5jBdiMfHYv9M_51HI9X4LbthbFlla1NdIbaTLU9Ix9EqYzjxA5SHZS-LOJ0b_hpdhnYDVI209qu02hE5LCobzB8m3882ENeb1E6_DL6vB_4DQOB5hFdBEKlJcsLgT5MmFjoVOiQFglXgpkwLgueG0QYGD-WFCOLhEoELFqVPFc6zBXVDJ_7AB5KFkdWx-S4C_Yii-Mdgk1ZgHHg2BfdhywZVDM7KDOSaKWSZXf4F8b9s1TzN983fAKPPWglu42UPYWVourB-m6FAftFTbaJKyN15_M9WDvy2foebJ82c7HrHTK6a_Oa77g7uonZ9TqcnMwm04kh39EHolclbnE5sSUogS-xX9TEnV2iXpCR32pBJhVpuqhq4nIRBK2gPVaaP4Oze-HDc1itplXxEojWmhXaSG3CnKeiTKnCx2gWacUZNUkfPrR_eKb9GHS7jeNn5tLxLMmQPZllD0ZFSL3VUc-a8R__oNtseZd5IzDP7kS2D--6y6i-NieTV8X02tLQ0PYmM96HFw2rux_CT6UUMVYf5JIQdAR2NPjylWryw40IjzFmQiy78f_XegtrqEPZt4Pjw1fwCL8laQ6XNmF1cXVdvEa4tVBvnFwTOL9vRfoFM1U_XQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Opioid+Release+after+High-Intensity+Interval+Training+in+Healthy+Human+Subjects&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Saanijoki%2C+Tiina&rft.au=Tuominen%2C+Lauri&rft.au=Tuulari%2C+Jetro+J&rft.au=Nummenmaa%2C+Lauri&rft.date=2018-01-01&rft.pub=Nature+Publishing+Group&rft.issn=0893-133X&rft.eissn=1740-634X&rft.volume=43&rft.issue=2&rft.spage=246&rft.epage=254&rft_id=info:doi/10.1038%2Fnpp.2017.148&rft_id=info%3Apmid%2F28722022&rft.externalDocID=PMC5729560 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon |